Welcome to the ECCMID 2021 programme page. 
We inform you that times mentioned on the programme refer to Central European Summer Time (CEST). Please make sure to take this into account when planning your attendance to the event. 

Please find below the colour code:

  • Orange: Educational Workshops, Meet-the-Expert Sessions
  • Green: Integrated Symposia
  • Light blue: Symposia
  • Dark blue: Keynote Lectures
  • Grey: Special Sessions

 

1. Viral infections
2. Bacterial infection
3. Antimicrobial resistance
4. Diagnostics
5. Antimicrobials & stewardship
6. Fungal infections
7. Parasites & international health
8. Infection prevention & control
9. Basic microbiology
10. Immunology & vaccinology
11. Special sessions & Other
12. COVID-19
13. Integrated sessions - 1
14. Integrated Sessions – 2
15. Integrated Sessions – 3
16. Integrated Sessions – 4
all day
08:00
 
 
 
 
 
09:00
 
 
 
 
 
10:00
 
 
 
 
 
11:00
 
 
 
 
 
12:00
 
 
 
 
 
13:00
 
 
 
 
 
14:00
 
 
 
 
 
15:00
 
 
 
 
 
16:00
 
 
 
 
 
17:00
 
 
 
 
 
18:00
 
 
 
 
 
19:00
 
 
 
 
 
20:00
 
 
 
 
                
                
                
2648 Hot topics in HIV infection 1. Viral infection & disease 1,5-hour Symposium 1a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
S26 Updates from patients with bacterial infection from the time of COVID-19 to the time of the Black Death 2. Bacterial infection & disease 1-hour Oral Case Session
2166 Antimicrobial susceptibility testing with EUCAST methods and breakpoints 3. Bacterial susceptibility & resistance 2,5-hour Educational Workshop 3c. Susceptibility testing methods (incl assay validation and comparative studies, excl TB)
2645 Multiplexed diagnostic panels: benefits, pitfalls and clinical applicability 4. Diagnostic bacteriology & general microbiology Meet-the-Expert Session 4d. Molecular diagnostics (incl POCT and syndromic testing)
 
2183 Improving the impact of fungal diagnostic tests on patient management 6. Fungal infection & disease 1-hour Symposium 6b. Diagnostic mycology (incl molecular)
S24 Malaria: diagnosis and resistance 7. Parasitic diseases & international health 1-hour Oral Session
S82 Reducing the burden of transmissions 8. Healthcare-associated & nosocomial infections, infection control 1-hour Oral Session
 
S8 Advances in understanding immune responses to important human pathogens 10. Immunology & vaccinology 1-hour Mini Oral Flash
 
S56 COVID-19 and thromboembolic disease 12. COVID-19 1-hour Oral Session
    
                
                
          
2619 Medical guideline development during and after the pandemic 11. Other 1,5-hour Educational Workshop 11b. Publishing, ethics, other academic and professional affairs
     
                
                
 
2620 Guidelines on Nontuberculous mycobacterial pulmonary disease 2. Bacterial infection & disease Meet-the-Expert Session 2a. Tuberculosis and other mycobacterial infections (incl antimycobacterial drugs, treatment & susceptibility/resistance, diagnostics & epidemiology)
 
2205 How to implement NGS into routine clinical diagnostics and microbial typing? 4. Diagnostic bacteriology & general microbiology Meet-the-Expert Session 4f. Whole genome sequencing (diagnostic, typing)
S11 Innovative PK/PD approaches to improve dosing 5. New antibacterial agents, PK/PD & Stewardship 1-hour Mini Oral Flash
      
S125 COVID-19 across healthcare systems 12. COVID-19 1-hour Mini Oral Flash
    
                
                
                
                
                
                
S110 HIV infection: clinical considerations 1. Viral infection & disease 1,5-hour Oral Session
2229 Prevention of endocarditis 2. Bacterial infection & disease 1,5-hour Educational Workshop 2b. Severe sepsis, bacteraemia & endocarditis (incl host bio-markers)
 
S53 Machine learning, artificial intelligence and novel applications in diagnostic microbiology 4. Diagnostic bacteriology & general microbiology 1-hour Mini Oral Flash
S48 Multidisciplinary science underpins antimicrobial stewardship 5. New antibacterial agents, PK/PD & Stewardship 1,5-hour Oral Session
 
S81 Parasites full of surprises 7. Parasitic diseases & international health 1,5-hour Case Session
2343 How to implement effective antimicrobial stewardship linked to infection prevention 8. Healthcare-associated & nosocomial infections, infection control 1,5-hour Educational Workshop 8g. Infection control interventions and trials (incl. microbiota transplantation)
2479 Looking deeper into the microbiota 9. Experimental microbiology, microbial pathogenesis & biofilm 1,5-hour Symposium 9b. Host-pathogen interaction (including basic microbiome studies)
 
2685 Year in Infectious Diseases 11. Other 1-hour Symposium 11c. Other
S91 COVID-19 in high risk patient populations 12. COVID-19 1,5-hour Oral Session
    
                
                
     
2146 Candida auris and global health aspects 6. Fungal infection & disease 1-hour Symposium
          
                
                
                
                
                
                
                
                
                
                
                
2559 From bats to environmental change: a One Health approach to pandemic preparedness 1. Viral infection & disease 1-hour Symposium 1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (all aspects)/resistance, excl clinical studies in immunocompromised hosts)
2364 Molecular testing for genital mycoplasmas and ureaplasmas in asymptomatic individuals 2. Bacterial infection & disease 1-hour Symposium 2e. Skin, soft tissue, bone & joint (excl prostheses) & central nervous system infections
2347 The immune system of bacteria: CRISPR and beyond 3. Bacterial susceptibility & resistance Keynote Lecture 3d. Resistance mechanisms (excl TB)
  
S103 News in the antifungal world: new drugs and resistance mechanisms 6. Fungal infection & disease 1-hour Oral Session
    
2664 Young Investigator Award lectures 11. Other Special Session 11c. Other
S57 Pathophysiology of COVID-19 12. COVID-19 1-hour Oral Session
2692 Revising the paradigm: the Importance of adult vaccination against respiratory diseases 11. Other 2-hour Integrated Symposium 11c. Other
2788 The challenges of managing the COVID-19 pandemic from pre-analytic to diagnosis 11. Other 1-hour Integrated Symposium 11c. Other
2789 Viruses mutate, and SARS-CoV-2 is no exception. Emerging mutation surveillance and confirmation 11. Other 2-hour Integrated Symposium 11c. Other
 
                
                
                
                
                
S105 Epidemiology of HIV infection 1. Viral infection & disease 1-hour Oral Session
S59 Urinary and genital infections: what is new? 2. Bacterial infection & disease 1-hour Oral Session
S5 Paediatric bloodstream infections: from neonates to children 2. Bacterial infection & disease 1-hour Mini Oral Flash
 
S111 Diagnostic value of metagenomics 4. Diagnostic bacteriology & general microbiology 1-hour Oral Session
2662 Public Health approach to integrated antimicrobial stewardship: what needs to be done 5. New antibacterial agents, PK/PD & Stewardship Keynote Lecture 5f. Other
2531 Fungal mycobiota in beach sand and water: relevance to public health 6. Fungal infection & disease 1-hour Symposium 6e. Other
  
2480 Biofilms as hot spots for the development and transmission of antimicrobial resistance 9. Experimental microbiology, microbial pathogenesis & biofilm 1-hour Symposium 9a. Microbial pathogenesis & virulence
  
S113 Epidemiology of COVID-19 around the world 12. COVID-19 1-hour Mini Oral Flash
   
2795 Developing new vaccines to protect against infectious diseases at home and abroad 11. Other 1-hour Integrated Symposium 11c. Other
                
                
                
                
                
            
2797 How the pandemic changed the pathway of diagnosis of infectious diseases: rapid diagnostic solutions for COVID-19 11. Other 1-hour Integrated Symposium 11c. Other
   
                
S117 Emerging vector-borne and zoonotic viruses 1. Viral infection & disease 1,5-hour Oral Session
2654 Challenges of treating bacterial infections in elderly patients 2. Bacterial infection & disease 1,5-hour Symposium 2b. Severe sepsis, bacteraemia & endocarditis (incl host bio-markers)
2656 Success stories of antibiotic resistance plasmids 3. Bacterial susceptibility & resistance 1,5-hour Symposium 3g. Spread of resistance incl reservoirs, ecology, mobile elements (excl nosocomial transmission)
2396 The gut microbiome: not only bacteria, but also parasites and fungi! 4. Diagnostic bacteriology & general microbiology 1,5-hour Symposium 4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
S22 New modalities for improving antimicrobial stewardship 5. New antibacterial agents, PK/PD & Stewardship 1-hour Oral Session
  
2547 Research on diagnosis and antimicrobial treatment of biofilm-related bone and prosthetic joint infections 8. Healthcare-associated & nosocomial infections, infection control 1,5-hour Symposium 8b. Other foreign-body and implant infections
  
2773 WHO panel discussion - Sustainable and tailored response for antimicrobial resistance by narrowing the gap between research and policy 5. New antibacterial agents, PK/PD & Stewardship Special Session 5f. Other
S78 COVID-19: clinical diagnostics 12. COVID-19 1,5-hour Oral Session
    
                
                
                
            
2762 Importance of influenza vaccination in the COVID-19 environment 11. Other 2-hour Integrated Symposium 11c. Other
2711 Superbugs, Susceptibility & Stewardship: with more antibiotics available for multidrug-resistant Gram-negative bacterial infections, what's holding us back? 11. Other 2-hour Integrated Symposium 11c. Other
2694 Deciphering the data: Clinical impact of vaccines and monoclonal antibodies for COVID-19 11. Other 2-hour Integrated Symposium 11c. Other
2696 The role of patients in infectious disease research - from study participants to scientific partners 11. Other 1,5-hour Integrated Symposium 11c. Other
                
                
                
                
                
2598 Congenital CMV infection: state-of-the-art approach to diagnostics and treatment 1. Viral infection & disease Meet-the-Expert Session 1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
   
2274 MDR efflux: from basic science to efflux inhibitors 5. New antibacterial agents, PK/PD & Stewardship Keynote Lecture 5d. Pharmacoepidemiology (incl economics and cost-effectiveness), improved prescribing and antibiotic stewardship (incl decision-support / prediction tools, behavioural aspects)
   
S80 Perturbance of established microbial communities 9. Experimental microbiology, microbial pathogenesis & biofilm 1-hour Oral Session
 
2686 Year in Infection Control 11. Other 1-hour Symposium 11c. Other
2756 Limiting the lung damage of critically ill ventilated COVID-19 patients 12. COVID-19 1-hour Symposium 12c. Clinical features, case management, outcome
    
                
                
                
                
                
                
                
                
                
                
                
S116 Viral respiratory infections: not only COVID 1. Viral infection & disease 1,5-hour Oral Session
2372 Controversies in the management of sepsis in the solid organ transplant patient 2. Bacterial infection & disease 1,5-hour Educational Workshop 2b. Severe sepsis, bacteraemia & endocarditis (incl host bio-markers)
S76 New insights into emergence and spread of AMR Klebsiella pneumoniae 3. Bacterial susceptibility & resistance 1,5-hour Oral Session
 
S3 Antimicrobial utilisation in COVID times 5. New antibacterial agents, PK/PD & Stewardship 1-hour Mini Oral Flash
2319 What's new with dermatophytes? 6. Fungal infection & disease 1,5-hour Symposium 6a. Fungal disease epidemiology
2302 New spatial approaches for studying global health 7. Parasitic diseases & international health 1,5-hour Educational Workshop 7g. International & public health
S75 Novel insights and interventions to reduce healthcare-associated infections 8. Healthcare-associated & nosocomial infections, infection control 1,5-hour Oral Session
2556 Building and destroying a biofilm 9. Experimental microbiology, microbial pathogenesis & biofilm 1,5-hour Educational Workshop 9a. Microbial pathogenesis & virulence
2666 Update on new vaccines 10. Immunology & vaccinology 1,5-hour Symposium 10g. Other
 
S100 COVID-19 vulnerability and the socially disadvantaged 12. COVID-19 1,5-hour Oral Session
    
                
                
                
                
                
                
                
                
                

Please note that times mentioned on the programme refer to Central European Summer Time (CEST).

Copyright © key4events - All rights reserved